Autonomous control of terminal erythropoiesis via physical interactions among erythroid cells

Stem Cell Research

Volumn 10, Issue 3, 2013, Pages 442-453

  Choi, Hye Sook ^a   Lee, Eun Mi ^a   Kim, Hyun Ok ^b   Park, Moon Il ^a   Baek, Eun Jung ^a  

^a Hanyang University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DELETED IN LIVER CANCER 1; INTERCELLULAR ADHESION MOLECULE 4; MESSENGER RNA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DENSITY; CELL GROWTH; CELL INTERACTION; CELL VIABILITY; ERYTHROBLAST; ERYTHROID CELL; ERYTHROPOIESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MOLECULAR MIMICRY; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; UMBILICAL CORD BLOOD;

CELL ADHESION MOLECULES; CELL COMMUNICATION; CELL LINEAGE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINESIS; ERYTHROBLASTS; ERYTHROPOIESIS; FETAL BLOOD; GTPASE-ACTIVATING PROTEINS; HUMANS; K562 CELLS; MACROPHAGES; PROTEIN BINDING; RECOMBINANT PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84875268240     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.02.003     Document Type: Article

References (38)

1. Allen T.D., Dexter T.M. Ultrastructural aspects of erythropoietic differentiation in long-term bone marrow culture. Differentiation 1982, 21:86-94.
2. Baek E.J., Kim H.S., Kim J.H., Choi T.Y., Kim H.O. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells. Transfusion 2008, 48:2235-2245.
3. Baek E.J., Kim H.S., Kim J.H., Kim N.J., Kim H.O. Stroma-free mass production of clinical grade red blood cells by using poloxamer 188 as a RBC survival enhancer. Transfusion 2009, 49:2285-2295.
4. Baek E.J., You J., Kim M.S., Lee S.Y., Cho S.J., Kim E., Kim H.O. Enhanced production of red blood cells in suspension by electrostatic interactions with culture plates. Tissue Eng. Part C 2010, 16:1325-1334.
5. Bain B.J., Clark D.M., Lampert I.A. Bone Marrow Pathology 1996, Blackwell Science, Oxford; Cambridge, Mass., USA.
6. Bessis M. Erythroblastic island, functional unity of bone marrow. Rev. Hematol. 1958, 13:8-11.
7. Burridge K., Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu. Rev. Cell Dev. Biol. 1996, 12:463-518.
8. Chan L.K., Ko F.C.F., Ng I.O.L., Yam J.W.P. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for tensin2 PTB domain interaction and is required for tumor-suppressive function. PLoS One 2009, 4:e5572.
9. Chasis J.A. Erythroblastic islands: specialized microenvironmental niches for erythropoiesis. Curr. Opin. Hematol. 2006, 13:137-141.
10. Chasis J.A., Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 2008, 112:470-478.
11. Eshghi S., Vogelezang M.G., Hynes R.O., Griffith L.G., Lodish H.F. Alpha4beta1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development. J. Cell Biol. 2007, 177:871-880.
12. Etienne S., Adamson P., Greenwood J., Strosberg A.D., Cazaubon S., Couraud P.O. ICAM-1 signaling pathways associated with rho activation in microvascular brain endothelial cells. J. Immunol. 1998, 161:5755-5761.
13. Gabet A.S., Coulon S., Fricot A., Vandekerckhove J., Chang Y., Ribeil J.A., Lordier L., Zermati Y., Asnafi V., Belaid Z., et al. Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling. Cell Death Differ. 2011, 18:678-689.
14. Healy K.D., Hodgson L., Kim T., Shutes A., Maddileti S., Juliano R.L., Hahn K.M., Harden T.K., Bang Y., Der C.J. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. Mol. Carcinog. 2008, 47:326-337.
15. Hermand P., Huet M., Callebaut I., Gane P., Ihanus E., Gahmberg C.G., Cartron J.P., Bailly P. Binding sites of leukocyte beta 2 integrins (LFA-1, Mac-1) on the human ICAM-4/LW blood group protein. J. Biol. Chem. 2000, 275:26002-26010.
16. Ihanus E., Uotila L.M., Toivanen A., Varis M., Gahmberg C.G. Red-cell ICAM-4 is a ligand for the monocyte/macrophage integrin CD11c/CD18: characterization of the binding sites on ICAM-4. Blood 2007, 109:802-810.
17. Ji P., Jayapal S.R., Lodish H.F. Enucleation of cultured mouse fetal erythroblasts requires Rac GTPases and mDia2. Nat. Cell Biol. 2008, 10:314-321.
18. Ji P., Yeh V., Ramirez T., Murata Hori M., Lodish H.F. Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts. Haematology 2010, 95:2013-2021.
19. Kim T.Y., Lee J.W., Kim H., Jong H., Jung M., Bang Y. DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 2007, 355:72-77.
20. Kim T.Y., Healy K.D., Der C.J., Sciaky N., Bang Y., Juliano R.L. Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration. J. Cell Biol. 2008, 283:32762-32770.
21. Kim T.Y., Kim I.S., Jong H.S., Lee J.W., Jung M., Bang Y.J. Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells. Exp. Mol. Med. 2008, 40:639-646.
22. Kim T.Y., Vigil D., Der C.J., Juliano R.L. Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility. Cancer Metastasis Rev. 2009, 28:77-83.
23. Lee G., Spring F.A., Parsons S.F., Mankelow T.J., Peters L., Koury M.J., Mohandas N., Anstee D.J., Chasis J.A. Novel secreted isoform of adhesion molecule ICAM-4: potential regulator of membrane-associated ICAM-4 interactions. Blood 2003, 101:1790-1797.
24. Manwani D., Bieker J.J. The erythroblastic island. Curr. Top. Dev. Biol. 2008, 82:23-53.
25. Migliaccio G., Sanchez M., Masiello F., Tirelli V., Varricchio L., Whitsett C., Migliaccio A.R. Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplant. 2010, 19:453-469.
26. Miharada K., Hiroyama T., Sudo K., Nagasawa T., Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat. Biotechnol. 2006, 24:1255-1256.
27. Mohandas N., Chasis J.A. The erythroid niche: molecular processes occurring within erythroblastic islands. Transfus. Clin. Biol. 2010, 17:110-111.
28. Neu B., Sowemimo-Coker S.O., Meiselman H.J. Cell-cell affinity of senescent human erythrocytes. Biophys. J. 2003, 85:75-84.
29. Rhodes M., Kopsombut P., Bondurant M.C., Price J.O., Koury M.J. Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin. Blood 2008, 111:1700-1708.
30. Sand T., Condie R., Rosenberg A. Metabolic crowding effect in suspension of cultured lymphocytes. Blood 1977, 50:337-346.
31. Sato C., Kojima K., Nishizawa K., Ikawa Y. Early decrease in hyaluronidase-sensitive cell surface charge during the differentiation of Friend erythroleukemic cells by dimethyl sulfoxide. Cancer Res. 1979, 39:1113-1117.
32. Soni S., Bala S., Gwynn B., Sahr K.E., Peters L., Hanspal M. Absence of erythroblast macrophage protein (Emp) leads to failure of erythroblast nuclear extrusion. J. Biol. Chem. 2006, 281:20181-20189.
33. Spring F.A., Parsons S.F. Erythroid cell adhesion molecules. Transfus. Med. Rev. 2000, 14:351-363.
34. Spring F.A., Parsons S.F., Ortlepp S., Olsson M.L., Sessions R., Brady R.L., Anstee D.J. Intercellular adhesion molecule-4 binds alpha(4)beta(1) and alpha(V)-family integrins through novel integrin-binding mechanisms. Blood 2001, 98:458-466.
35. Telen M.J. Red blood cell surface adhesion molecules: their possible roles in normal human physiology and disease. Semin. Hematol. 2000, 37:130-142.
36. Tsiftsoglou A.S., Vizirianakis I.S., Strouboulis J. Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life 2009, 61:800-830.
37. Xue W., Krasnitz A., Lucito R., Sordella R., Vanaelst L., Cordon Cardo C., Singer S., Kuehnel F., Wigler M., Lowe S.W., et al. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev. 2008, 22:1439-1444.
38. Yuan B., Zhou X., Durkin M.E., Zimonjic D.B., Gumundsdottir K., Eyfjord J.E., Thorgeirsson S., Popescu N.C. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene 2003, 22:445-450.